About Vaxxas Vaxxas is a biotechnology company pioneering a needle-free vaccination technology designed to enhance immune response, reduce costs, and improve accessibility. The company recently ...

A wireless microchip implanted beneath the retina improved vision in 81% of patients with advanced age-related macular ...

Brisbane-based ObvioHealth has signed a three-year agreement with clinical-stage biotechnology company Vaxxas to support late-stage trials.

A new trial shows that a wireless subretinal implant, the PRIMA system, restored central vision in patients with geographic ...

Older adults experiencing irreversible blindness may now be able to see thanks to a system relying on a wireless retinal implant and high-tech glasses ...

Liz Wood, who lives in Beacon, is the founder of The MYT1L Project ( myraregene.org ), a foundation that supports families whose children are affected by a rare genetic disorder.

In a metal like copper, however, the outer electrons swim around freely and are shared by all the atoms. That’s why ...

Another trend has popped up as well, especially among remote and hybrid workers: Voluntarily working in fits and starts, as ...

MIT’s Daniela Rus is redefining robotics with empathy leading CSAIL and Liquid AI recent $250m series A to build technology ...

Geographic atrophy, an advanced form of dry age-related macular degeneration, leaves almost five million people around the ...

Thank you, Sabrina, and good morning, everyone. The third quarter was another exceptional quarter for GeneDx. Achieving that vision requires a fast-growing, disciplined, profitable business that ...

Mr. Proud, who became a U.S. citizen in 2019, put together a policy paper for the first Trump administration, calling for a ...